$1.51 -0.02 (%) Aveo Pharmaceuticals Inc - NASDAQ

Jul. 27, 2015 | 03:59 PM

Partner Headlines

  1. Morning Market Losers

    Benzinga | Jun. 12, 2015 | 10:00AM EST
  2. Mid-Day Market Update: Sigma Designs Surges On Upbeat Results; Boulder Brands Shares Drop

    Benzinga | Jun. 10, 2015 | 13:05PM EST
  3. Morning Market Gainers

    Benzinga | Jun. 4, 2015 | 09:42AM EST
  4. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 4, 2015 | 08:16AM EST
  5. Morning Market Losers

    Benzinga | Jun. 3, 2015 | 09:52AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 3, 2015 | 08:17AM EST
  7. Morning Market Gainers

    Benzinga | Jun. 2, 2015 | 09:42AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 2, 2015 | 08:07AM EST
  9. Morning Market Gainers

    Benzinga | May. 22, 2015 | 09:46AM EST
  10. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 22, 2015 | 08:20AM EST
  11. What's Up With The Delayed Reaction In Aveo Pharmaceuticals?

    Benzinga | May. 21, 2015 | 12:01PM EST
  12. Morning Market Gainers

    Benzinga | May. 21, 2015 | 09:49AM EST
  13. Morning Market Gainers

    Benzinga | May. 20, 2015 | 09:43AM EST
  14. AVEO Reports Presentation of Final Results of Extension Study 902, FDA Regulatory Feedback for Advancing Tivozanib in Renal Cell Carcinoma

    Benzinga | May. 20, 2015 | 07:03AM EST
  15. Klarman-Founded Baupost Group Increases Stake In eBay, Trims Micron and Citigroup In Q4

    Benzinga | Feb. 14, 2015 | 19:49PM EST
  16. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  17. US Stock Futures Surge Ahead Of ADP Report, Fed Minutes

    Benzinga | Jan. 7, 2015 | 07:06AM EST
  18. US Stock Futures Slightly Higher; Dollar Surges Against Yen

    Benzinga | Nov. 11, 2014 | 07:04AM EST
  19. AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibitor) For The Treatment Of Ocular Diseases

    Benzinga | Nov. 11, 2014 | 06:46AM EST
  20. AVEO Oncology Announces Lease Termination And Amendment To Debt Financing Facility

    Benzinga | Sep. 26, 2014 | 07:01AM EST
  21. 3 Biotech Stocks Backed By Big Money

    Benzinga | Jun. 16, 2014 | 14:27PM EST
  22. Morning Market Movers

    Benzinga | Apr. 10, 2014 | 09:42AM EST
  23. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 7, 2014 | 10:35AM EST
  24. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 04:51AM EST
  25. Benzinga Weekly Preview: Ukraine Tension Likely To Drive Markets

    Benzinga | Mar. 7, 2014 | 16:11PM EST
  26. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 16, 2013 | 10:35AM EST
  27. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 13, 2013 | 10:15AM EST
  28. Morning Market Losers

    Benzinga | Dec. 13, 2013 | 10:09AM EST
  29. US Stock Futures Gain Ahead Of Producer Price Index

    Benzinga | Dec. 13, 2013 | 07:07AM EST
  30. AVEO Says Tivozanib Trial in Colorectal Cancer Unlikely to Meet Primary Endpoint

    Benzinga | Dec. 13, 2013 | 06:53AM EST
  31. Wild Card Wonders, Shopping for 52-Week Lows

    GuruFocus | Sep. 28, 2013 | 23:04PM EST
  32. Sure Hope You Ignored This Dude on Aveo Stock

    YCharts | Sep. 16, 2013 | 15:43PM EST
  33. Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low

    GuruFocus | Sep. 3, 2013 | 14:52PM EST
  34. Cutting Loose: Seth Klarman's Active Second Quarter Selling and Trimming

    GuruFocus | Aug. 14, 2013 | 19:51PM EST
  35. 13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options

    Benzinga | Feb. 13, 2013 | 11:16AM EST
  36. A Peek Into The Market Before The Trading Starts

    Benzinga | Jan. 29, 2013 | 00:22AM EST
  37. AVEO, Astellas Announce Presentations of Tivozanib Clinical Data

    Benzinga | Jan. 28, 2013 | 23:51PM EST
  38. AVEO Pharmaceuticals Closes Public Offering

    Benzinga | Jan. 23, 2013 | 23:56PM EST
  39. Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA

    GuruFocus | Dec. 16, 2012 | 05:15AM EST
  40. AVEO Pharmaceuticals, Inc. (AVEO) CEO Ngoc Tuan Ha buys 75,000 Shares

    GuruFocus | Dec. 14, 2012 | 02:37AM EST
  41. A Peek Into The Market Before The Trading Starts

    Benzinga | Nov. 28, 2012 | 00:20AM EST
  42. AVEO, Astellas Announce FDA Acceptance of NDA Filing for Tivozanib

    Benzinga | Nov. 27, 2012 | 23:41PM EST
  43. UPDATE: Stifel Nicolaus Initiates AVEO Pharmaceuticals at Sell; Tivozanib Decision Likely Negative

    Benzinga | Nov. 14, 2012 | 04:22AM EST
  44. UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Aveo Pharmaceuticals

    Benzinga | Oct. 31, 2012 | 05:30AM EST
  45. AVEO Oncology Announces Strategic Restructuring

    Benzinga | Oct. 30, 2012 | 00:44AM EST
  46. AVEO and Astellas Announce Submission of New Drug Application for Tivozanib

    Benzinga | Sep. 28, 2012 | 01:48AM EST
  47. New Clinical Data on AVEO Oncology's Tivozanib and Ficlatuzumab to be Presented at ESMO 2012 Congress

    Benzinga | Sep. 20, 2012 | 00:39AM EST
  48. Health Care Sector Wrap

    FoxBusiness | Aug. 10, 2012 | 10:50AM EST
  49. Health Care Sector Wrap

    FoxBusiness | Aug. 8, 2012 | 10:46AM EST
  50. NxStage Medical, Assisted Living Concepts Among Stocks setting 52-Week Lows Wednesday

    FoxBusiness | Aug. 8, 2012 | 06:31AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!